HEADER HYDROLASE/HYDROLASE INHIBITOR 10-JAN-12 4D88 TITLE CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH NVP-BXQ490 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 48-447); COMPND 5 SYNONYM: ASPARTYL PROTEASE 2, ASP2, ASP 2, BETA-SITE AMYLOID COMPND 6 PRECURSOR PROTEIN CLEAVING ENZYME 1, BETA-SITE APP CLEAVING ENZYME 1, COMPND 7 MEMAPSIN-2, MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 8 EC: 3.4.23.46; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE, BACE1, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS BETA-SECRETASE, MEMAPSIN2, BACE1, ASPARTIC PROTEINASE, ALZHEIMER'S KEYWDS 2 DISEASE, ENZYME INHIBITOR COMPLEX, STRUCTURE-BASED DRUG DESIGN, KEYWDS 3 HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.RONDEAU,E.BOURGIER REVDAT 1 21-NOV-12 4D88 0 JRNL AUTH H.RUEEGER,R.LUEOEND,O.ROGEL,J.M.RONDEAU,H.MOBITZ,R.MACHAUER, JRNL AUTH 2 L.JACOBSON,M.STAUFENBIEL,S.DESRAYAUD,U.NEUMANN JRNL TITL DISCOVERY OF CYCLIC SULFONE HYDROXYETHYLAMINES AS POTENT AND JRNL TITL 2 SELECTIVE BETA-SITE APP-CLEAVING ENZYME 1 (BACE1) JRNL TITL 3 INHIBITORS: STRUCTURE BASED DESIGN AND IN VIVO REDUCTION OF JRNL TITL 4 AMYLOID BETA-PEPTIDES JRNL REF J.MED.CHEM. V. 55 3364 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22380629 JRNL DOI 10.1021/JM300069Y REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.RUEEGER,J.M.RONDEAU,C.MCCARTHY,H.MOEBITZ, REMARK 1 AUTH 2 M.TINTELNOT-BLOMLEY,U.NEUMANN,S.DESRAYAUD REMARK 1 TITL STRUCTURE-BASED DESIGN, SYNTHESIS AND SAR OF CYCLIC REMARK 1 TITL 2 HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 21 1942 2011 REMARK 1 REFN ISSN 0960-894X REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1723551.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 42415 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2121 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 42415 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6218 REMARK 3 BIN R VALUE (WORKING SET) : 0.2090 REMARK 3 BIN FREE R VALUE : 0.2360 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 327 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2953 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 548 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : 1.99000 REMARK 3 B33 (A**2) : -2.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.65 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.100 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 47.54 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 4 : NVP-BXQ490_S.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NVP-BXQ490_S.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4D88 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-12. REMARK 100 THE RCSB ID CODE IS RCSB070005. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42415 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 74.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.53 REMARK 200 R MERGE FOR SHELL (I) : 0.30700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.180 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX 2002 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 1,500 IN WATER, PH 5.2, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.43800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.28950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.44850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.28950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.43800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.44850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -15 REMARK 465 PRO A -14 REMARK 465 ASP A -13 REMARK 465 GLU A -12 REMARK 465 GLU A -11 REMARK 465 PRO A -10 REMARK 465 GLU A -9 REMARK 465 GLU A -8 REMARK 465 PRO A -7 REMARK 465 GLY A -6 REMARK 465 ARG A -5 REMARK 465 ARG A -4 REMARK 465 GLY A -3 REMARK 465 GLY A 157A REMARK 465 PHE A 157B REMARK 465 PRO A 157C REMARK 465 LEU A 157D REMARK 465 ASN A 157E REMARK 465 GLN A 157F REMARK 465 SER A 157G REMARK 465 GLU A 157H REMARK 465 VAL A 157I REMARK 465 LEU A 157J REMARK 465 ALA A 157K REMARK 465 SER A 157L REMARK 465 VAL A 157M REMARK 465 ILE A 373 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 114 14.39 82.44 REMARK 500 TRP A 184 -83.18 -136.26 REMARK 500 ASN A 196 58.09 36.16 REMARK 500 ASN A 280 15.32 59.62 REMARK 500 ALA A 310 35.99 -96.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BXQ A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VEU RELATED DB: PDB REMARK 900 COMPOUND 3 OF PRIMARY CITATION REMARK 900 RELATED ID: 3VF3 RELATED DB: PDB REMARK 900 ANALOGUE OF COMPOUND 14B OF PRIMARY CITATION REMARK 900 RELATED ID: 3VG1 RELATED DB: PDB REMARK 900 COMPOUND 32A OF PRIMARY CITATION, SOAK, P212121 REMARK 900 RELATED ID: 4D83 RELATED DB: PDB REMARK 900 COMPOUND 32A OF PRIMARY CITATION, CO-CRYSTALLIZATION, P21 REMARK 900 RELATED ID: 4D8C RELATED DB: PDB REMARK 900 RELATED ID: 4D88 RELATED DB: PDB REMARK 900 RELATED ID: 4D89 RELATED DB: PDB DBREF 4D88 A -13 373 UNP P56817 BACE1_HUMAN 48 447 SEQADV 4D88 GLY A -15 UNP P56817 EXPRESSION TAG SEQADV 4D88 PRO A -14 UNP P56817 EXPRESSION TAG SEQRES 1 A 402 GLY PRO ASP GLU GLU PRO GLU GLU PRO GLY ARG ARG GLY SEQRES 2 A 402 SER PHE VAL GLU MET VAL ASP ASN LEU ARG GLY LYS SER SEQRES 3 A 402 GLY GLN GLY TYR TYR VAL GLU MET THR VAL GLY SER PRO SEQRES 4 A 402 PRO GLN THR LEU ASN ILE LEU VAL ASP THR GLY SER SER SEQRES 5 A 402 ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO PHE LEU HIS SEQRES 6 A 402 ARG TYR TYR GLN ARG GLN LEU SER SER THR TYR ARG ASP SEQRES 7 A 402 LEU ARG LYS GLY VAL TYR VAL PRO TYR THR GLN GLY LYS SEQRES 8 A 402 TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SER ILE PRO SEQRES 9 A 402 HIS GLY PRO ASN VAL THR VAL ARG ALA ASN ILE ALA ALA SEQRES 10 A 402 ILE THR GLU SER ASP LYS PHE PHE ILE ASN GLY SER ASN SEQRES 11 A 402 TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA GLU ILE ALA SEQRES 12 A 402 ARG PRO ASP ASP SER LEU GLU PRO PHE PHE ASP SER LEU SEQRES 13 A 402 VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SER LEU GLN SEQRES 14 A 402 LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SER GLU VAL SEQRES 15 A 402 LEU ALA SER VAL GLY GLY SER MET ILE ILE GLY GLY ILE SEQRES 16 A 402 ASP HIS SER LEU TYR THR GLY SER LEU TRP TYR THR PRO SEQRES 17 A 402 ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE ILE VAL ARG SEQRES 18 A 402 VAL GLU ILE ASN GLY GLN ASP LEU LYS MET ASP CYS LYS SEQRES 19 A 402 GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SER GLY THR SEQRES 20 A 402 THR ASN LEU ARG LEU PRO LYS LYS VAL PHE GLU ALA ALA SEQRES 21 A 402 VAL LYS SER ILE LYS ALA ALA SER SER THR GLU LYS PHE SEQRES 22 A 402 PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU VAL CYS TRP SEQRES 23 A 402 GLN ALA GLY THR THR PRO TRP ASN ILE PHE PRO VAL ILE SEQRES 24 A 402 SER LEU TYR LEU MET GLY GLU VAL THR ASN GLN SER PHE SEQRES 25 A 402 ARG ILE THR ILE LEU PRO GLN GLN TYR LEU ARG PRO VAL SEQRES 26 A 402 GLU ASP VAL ALA THR SER GLN ASP ASP CYS TYR LYS PHE SEQRES 27 A 402 ALA ILE SER GLN SER SER THR GLY THR VAL MET GLY ALA SEQRES 28 A 402 VAL ILE MET GLU GLY PHE TYR VAL VAL PHE ASP ARG ALA SEQRES 29 A 402 ARG LYS ARG ILE GLY PHE ALA VAL SER ALA CYS HIS VAL SEQRES 30 A 402 HIS ASP GLU PHE ARG THR ALA ALA VAL GLU GLY PRO PHE SEQRES 31 A 402 VAL THR LEU ASP MET GLU ASP CYS GLY TYR ASN ILE HET BXQ A 401 37 HETNAM BXQ (3S,4S,5R)-3-{4-AMINO-3-FLUORO-5-[(2S)-3,3,3-TRIFLUORO- HETNAM 2 BXQ 2-HYDROXYPROPYL]BENZYL}-5-[(3-TERT-BUTYLBENZYL) HETNAM 3 BXQ AMINO]TETRAHYDRO-2H-THIOPYRAN-4-OL 1,1-DIOXIDE FORMUL 2 BXQ C26 H34 F4 N2 O4 S FORMUL 3 HOH *548(H2 O) HELIX 1 1 SER A -2 VAL A 3 1 6 HELIX 2 2 GLN A 53 SER A 57 5 5 HELIX 3 3 TYR A 123 ALA A 127 5 5 HELIX 4 4 PRO A 135 HIS A 145 1 11 HELIX 5 5 ASP A 167 SER A 169 5 3 HELIX 6 6 ASP A 203 TYR A 209 5 7 HELIX 7 7 LYS A 225 SER A 239 1 15 HELIX 8 8 GLY A 247 GLY A 251 5 5 HELIX 9 9 PRO A 263 PHE A 267 5 5 HELIX 10 10 LEU A 288 TYR A 292 1 5 HELIX 11 11 ASP A 298 SER A 302 5 5 HELIX 12 12 GLY A 321 GLU A 326 1 6 HELIX 13 13 ARG A 334 ARG A 336 5 3 SHEET 1 A 8 LEU A 6 LYS A 9 0 SHEET 2 A 8 GLY A 13 VAL A 20 -1 O TYR A 15 N ARG A 7 SHEET 3 A 8 GLN A 25 ASP A 32 -1 O ILE A 29 N VAL A 16 SHEET 4 A 8 GLY A 117 GLY A 120 1 O LEU A 119 N LEU A 30 SHEET 5 A 8 PHE A 38 GLY A 41 -1 N ALA A 39 O ILE A 118 SHEET 6 A 8 THR A 94 ASP A 106 1 O ILE A 102 N VAL A 40 SHEET 7 A 8 LYS A 75 SER A 86 -1 N VAL A 85 O VAL A 95 SHEET 8 A 8 ARG A 61 PRO A 70 -1 N LYS A 65 O LEU A 80 SHEET 1 B 4 LEU A 6 LYS A 9 0 SHEET 2 B 4 GLY A 13 VAL A 20 -1 O TYR A 15 N ARG A 7 SHEET 3 B 4 LYS A 75 SER A 86 -1 O SER A 86 N THR A 19 SHEET 4 B 4 ARG A 61 PRO A 70 -1 N LYS A 65 O LEU A 80 SHEET 1 C 5 GLY A 159 ILE A 163 0 SHEET 2 C 5 PHE A 150 LEU A 154 -1 N GLN A 153 O SER A 160 SHEET 3 C 5 PHE A 328 ASP A 333 -1 O PHE A 332 N PHE A 150 SHEET 4 C 5 ARG A 338 SER A 344 -1 O ALA A 342 N TYR A 329 SHEET 5 C 5 TYR A 171 PRO A 179 -1 N THR A 178 O ILE A 339 SHEET 1 D 5 GLU A 187 VAL A 188 0 SHEET 2 D 5 SER A 212 VAL A 214 -1 O SER A 212 N VAL A 188 SHEET 3 D 5 THR A 318 MET A 320 1 O MET A 320 N ILE A 213 SHEET 4 D 5 LEU A 221 PRO A 224 -1 N ARG A 222 O VAL A 319 SHEET 5 D 5 ILE A 311 SER A 314 1 O SER A 314 N LEU A 223 SHEET 1 E 5 GLN A 198 ASP A 199 0 SHEET 2 E 5 ILE A 190 ILE A 195 -1 N ILE A 195 O GLN A 198 SHEET 3 E 5 ILE A 270 MET A 275 -1 O SER A 271 N GLU A 194 SHEET 4 E 5 GLN A 281 ILE A 287 -1 O ILE A 287 N ILE A 270 SHEET 5 E 5 ALA A 356 VAL A 362 -1 O GLU A 358 N ARG A 284 SHEET 1 F 3 VAL A 255 GLN A 258 0 SHEET 2 F 3 ASP A 304 PHE A 309 -1 O TYR A 307 N VAL A 255 SHEET 3 F 3 LEU A 293 PRO A 295 -1 N ARG A 294 O LYS A 308 SSBOND 1 CYS A 155 CYS A 346 1555 1555 2.03 SSBOND 2 CYS A 204 CYS A 369 1555 1555 2.04 SSBOND 3 CYS A 256 CYS A 306 1555 1555 2.03 CISPEP 1 SER A 22 PRO A 23 0 -4.47 CISPEP 2 ARG A 128 PRO A 129 0 2.61 CISPEP 3 TYR A 209 ASP A 210 0 5.24 CISPEP 4 GLY A 359 PRO A 360 0 -0.13 SITE 1 AC1 27 SER A 10 GLY A 11 GLN A 12 GLY A 13 SITE 2 AC1 27 LEU A 30 ASP A 32 GLY A 34 SER A 35 SITE 3 AC1 27 PRO A 70 TYR A 71 THR A 72 GLN A 73 SITE 4 AC1 27 LYS A 107 PHE A 108 ILE A 110 TRP A 115 SITE 5 AC1 27 ILE A 126 ARG A 128 ASP A 215 GLY A 217 SITE 6 AC1 27 THR A 218 THR A 219 HOH A 605 HOH A 754 SITE 7 AC1 27 HOH A 766 HOH A 941 HOH A 982 CRYST1 48.876 74.897 104.579 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020460 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013352 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009562 0.00000